738 results match your criteria pityriasis rosea


Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.

Medicine (Baltimore) 2021 Apr;100(14):e25352

Lucian Blaga University of Sibiu, Faculty of Medicine Sibiu, Academic Emergency Hospital Sibiu - Dermatology Clinic, Sibiu, Romania.

Rationale: Pityriasis rosea Gibert is an erythematous-papulosquamous dermatosis that frequently occurs in young adults. The etiopathogenesis of PR is still unknown, but is frequently associated with episodes of upper respiratory tract infections. It is likely that a new viral trigger of pityriasis rosea is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Read More

View Article and Full-Text PDF

Symmetric blaschkoid pityriasis rosea in a child.

Pediatr Dermatol 2021 Mar 19. Epub 2021 Mar 19.

Department of Dermatology, Venereology, and Leprosy, R.G.Kar Medical College, Kolkata, India.

Pityriasis rosea (PR) is a common papulosquamous disorder that may be related to primary infection or endogenous reactivation of human herpesvirus 7 and 6. Based on morphology, distribution, and size of lesions, several atypical variants of PR have been described. PR following the lines of Blaschko represents an atypical variant that has seldom been described in the literature. Read More

View Article and Full-Text PDF

Pityriasis Rosea-like Eruption Induced by Imatinib in a Patient With a Gastrointestinal Stromal Tumor.

Actas Dermosifiliogr 2021 Mar 3. Epub 2021 Mar 3.

Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Puerta del Mar, Cádiz, España.

View Article and Full-Text PDF

Dermoscopy Differentiates Guttate Psoriasis from a Mimicker-Pityriasis Rosea.

Dermatol Pract Concept 2021 Jan 29;11(1):e2021138. Epub 2021 Jan 29.

Department of Pathology, HBT Medical College & Dr. R.N. Cooper Hospital, Mumbai, India.

Background: Guttate psoriasis (GP) and pityriasis rosea (PR) are a part of papulosquamous disorders that have very similar clinical features and often require histopathology to confirm the diagnosis. Dermoscopy has emerged as a noninvasive, cost-effective technique that can aid in the diagnosis of inflammatory skin diseases like GP and PR.

Objective: To study and compare the dermoscopic features of GP and PR. Read More

View Article and Full-Text PDF
January 2021

A convolutional neural network architecture for the recognition of cutaneous manifestations of COVID-19.

Dermatol Ther 2021 Mar 28;34(2):e14902. Epub 2021 Feb 28.

Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.

During the COVID-19 pandemic, dermatologists reported an array of different cutaneous manifestations of the disease. It is challenging to discriminate COVID-19-related cutaneous manifestations from other closely resembling skin lesions. The aim of this study was to generate and evaluate a novel CNN (Convolutional Neural Network) ensemble architecture for detection of COVID-19-associated skin lesions from clinical images. Read More

View Article and Full-Text PDF

A multiplex real-time PCR quantitation of human herpesvirus-6, 7, 8 viruses: application in blood transfusions.

Virol J 2021 02 18;18(1):38. Epub 2021 Feb 18.

Department of Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, Hubei, China.

Background: In recent years, fluorescent quantitative polymerase chain reaction assays for detecting viral DNA are in widespread use throughout the world. However, considering the wide distribution of new herpesvirus among the population, we constructed a method to detect HHV-6, 7, and 8 simultaneously.

Methods: The blood samples of 74 blood donors and 45 pityriasis rosea patients were collected. Read More

View Article and Full-Text PDF
February 2021

Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends.

Dermatol Ther 2021 Mar 25;34(2):e14895. Epub 2021 Feb 25.

Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey.

Coronavirus disease 2019 (COVID-19) pandemic had substantial effect both on daily life and medical practice. Internet data have been used to analyze the trends in public interest in various medical conditions and treatments. The aim of this study is to analyze the public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic. Read More

View Article and Full-Text PDF

Cutaneous manifestations of COVID-19.

Dermatol Online J 2021 Jan 15;27(1). Epub 2021 Jan 15.

Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA.

The severe acute respiratory syndrome coronavirus two (SARS-CoV-2), which causes the 2019 coronavirus disease (COVID-19), has infected patients worldwide. Physicians have increasingly identified cutaneous findings as a significant clinical manifestation of COVID-19. In this review, we describe the clinical presentation, onset, duration, associated symptoms, treatment, and outcome of cutaneous manifestations thus far reported to be related to COVID-19. Read More

View Article and Full-Text PDF
January 2021

Dermoscopy in general dermatology (non-neoplastic dermatoses): pitfalls and tips.

Authors:
Enzo Errichetti

Int J Dermatol 2021 Feb 3. Epub 2021 Feb 3.

Institute of Dermatology, "Santa Maria della Misericordia" University Hospital, Udine, Italy.

Background: Dermoscopy is gaining appreciation in the spectrum of non-neoplastic skin conditions, especially papulosquamous and granulomatous dermatoses. However, the use of dermoscopy in such diseases has not yet acquired a standard role in daily practice due to the lack of a structured approach as well as possible pitfalls limiting its accuracy.

Methods: A descriptive analysis of the most common limitations/pitfalls described in the literature regarding dermoscopy of non-neoplastic dermatoses was performed, also providing possible tips to deal with them. Read More

View Article and Full-Text PDF
February 2021

SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.

Br J Dermatol 2021 Jan 28. Epub 2021 Jan 28.

Internal Medicine Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.

View Article and Full-Text PDF
January 2021

Pigmented purpuric dermatosis: Ten years of experience in a tertiary hospital and awareness of mycosis fungoides in differential diagnosis.

J Cutan Pathol 2021 May 18;48(5):611-616. Epub 2021 Jan 18.

Department of Pathology, Istanbul Haseki Training and Research Hospital, Istanbul, Turkey.

Background: Pigmented purpuric dermatoses (PPD) can clinically mimic many diseases. Histopathology provides a definitive diagnosis. The aim of the study is to reveal the features of patients with PPD and to determine the disease frequency in the differential diagnosis, especially mycosis fungoides (MF). Read More

View Article and Full-Text PDF

L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review.

Dermatol Ther 2021 Jan 30;34(1):e14679. Epub 2020 Dec 30.

Department of Biosciences, Piracicaba Dental School - UNICAMP, Piracicaba, Brazil.

Pityriasis rosea (PR) is a dermatological disease with an erythemato-papulosquamous manifestation, distributed on the trunk and extremities affecting healthy people, especially children and young people between 10 and 35 years of age. The evolution is 6 to 8 weeks and may remain for 3 to 6 months. It regresses spontaneously and can leave changes in the skin color but reversibly. Read More

View Article and Full-Text PDF
January 2021

Dermoscopic characterization of guttate psoriasis, pityriasis rosea, and pityriasis lichenoides chronica in dark skin phototypes: An observational study.

Dermatol Ther 2021 Jan 13;34(1):e14631. Epub 2020 Dec 13.

Department of Dermatology, Venereology and Leprosy, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India.

Dermoscopy as a diagnostic tool is attaining impetus in inflammatory dermatoses with the cumulative description of characteristic findings in most dermatoses obviating at times the need of biopsy. In this retrospective observational study, 20 histopathology confirmed cases each of pityriasis rosea (PR), guttate psoriasis (GP), and pityriasis lichenoides chronica (PLC) seen over a period of 3 years were included. Dermoscopy images were extracted from photography archives for evaluation and three lesions from each patient (60 lesions each) were analyzed. Read More

View Article and Full-Text PDF
January 2021

Pityriasis rosea as a leading manifestation of COVID-19 infection.

J Eur Acad Dermatol Venereol 2021 Apr 23;35(4):e246-e247. Epub 2020 Dec 23.

Department of Dermatology, Hotel Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

View Article and Full-Text PDF

Pityriasis Rosea Unilateralis: A Rare Presentation in Two Females.

Indian Dermatol Online J 2020 Sep-Oct;11(5):823-825. Epub 2020 Sep 19.

Department of Dermatology and STD, Lady Hardinge Medical College and Associated Hospital, New Delhi, India.

View Article and Full-Text PDF
September 2020

Pityriasis rosea-like eruption revealing COVID-19.

Australas J Dermatol 2020 Nov 20. Epub 2020 Nov 20.

Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

View Article and Full-Text PDF
November 2020

Skin manifestations of COVID-19 in children: Part 3.

Clin Exp Dermatol 2021 Apr 18;46(3):462-472. Epub 2020 Nov 18.

Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage of those infected. As time has passed, other symptoms have been recognized. Read More

View Article and Full-Text PDF

Pityriasis rosea and COVID-19.

J Med Virol 2020 Nov 18. Epub 2020 Nov 18.

Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS Ca' Granda Ospedale Maggiore, Policlinico.

View Article and Full-Text PDF
November 2020

Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey.

Dermatol Ther 2020 11 9;33(6):e14485. Epub 2020 Nov 9.

Faculty of Medicine, Department of Dermatology, Akdeniz University, Antalya, Turkey.

COVID-19 pandemic has a significant impact on public health, whether directly or indirectly. The first case was seen in Turkey on March 11, and the World Health Organization (WHO) declared a pandemic on March 12, 2020. The study aimed to document the effect of pandemic on dermatology outpatient clinics in Turkey. Read More

View Article and Full-Text PDF
November 2020

Atypical Palmoplantar Pityriasis Rosea.

Actas Dermosifiliogr 2021 Apr 29;112(4):372-374. Epub 2020 Oct 29.

Servicio de Dermatología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España.

View Article and Full-Text PDF

Emergency dermatology: Three-month experience from an Italian academic outpatient clinic during lockdown for COVID-19 pandemic.

Dermatol Ther 2020 11 20;33(6):e14390. Epub 2020 Oct 20.

Department of Dermatology and Venereology, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

Dermatology is a field of medicine where urgent cases occur commonly. However, access to specialized emergency dermatology services is very limited. Following the declaration of the COVID-19 pandemic, the cessation of all elective dermatology visits was widely urged. Read More

View Article and Full-Text PDF
November 2020

Differentiation of inflammatory papulosquamous skin diseases based on skin biophysical and ultrasonographic properties: A decision tree model.

Indian J Dermatol Venereol Leprol 2020 Nov-Dec;86(6):752

Center for Research and Training in Skin Diseases and Leprosy; Clinical Trial Center, Tehran University of Medical Sciences, Tehran, Iran.

Background: The biophysical and ultrasonographic properties of the skin change in papulosquamous diseases.

Aims: : To identify biophysical and ultrasonographic properties for the differentiation of five main groups of papulosquamous skin diseases.

Methods: Fifteen biophysical and ultrasonographic parameters were measured by multiprobe adapter system and high-frequency ultrasonography in active lesions and normal control skin in patients with chronic eczema, psoriasis, lichen planus, pityriasis rosea and parapsoriasis/mycosis fungoides. Read More

View Article and Full-Text PDF
October 2020

Histological and immunohistopathological differentiation between guttate psoriasis and pityriasis rosea.

Australas J Dermatol 2020 Nov 6;61(4):e481-e484. Epub 2020 Jul 6.

Department of Dermatology, Hallym University Sacred Heart Hospital, Anyang, Korea.

View Article and Full-Text PDF
November 2020

Pityriasis rosea during omalizumab treatment for chronic spontaneous urticaria.

Dermatol Ther 2020 11 10;33(6):e14356. Epub 2020 Oct 10.

Dermatology Unit, Ospedale Policlinico San Martino, Genoa, Italy.

Pityriasis rosea (PR) is an exanthematous disease whose etiology is related to reactivation of herpes human herpesviruses 6 (HHV-6) and 7 (HHV-7). We observed two cases of PR arising during omalizumab therapy for chronic spontaneous urticaria (CSU). Here we report for the first time PR occurring during omalizumab treatment. Read More

View Article and Full-Text PDF
November 2020

Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.

J Med Virol 2021 04 7;93(4):1850-1851. Epub 2020 Oct 7.

Dermatology Unit, Ospedale Policlinico San Martino, Genoa, Italy.

View Article and Full-Text PDF

Pityriasis Rosea: An Updated Review.

Curr Pediatr Rev 2020 Sep 23. Epub 2020 Sep 23.

Department of Paediatrics, The Chinese University of Hong Kong, and Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital. Hong Kong.

Background: Pityriasis rosea is a common acute, self-limited papulosquamous dermatosis that primarily affects children and young adults. The condition and its clinical variants may pose a diagnostic challenge, especially in the absence of the herald patch.

Objective: This article aimed to familiarize pediatricians with clinical manifestations, evaluation, diagnosis, and management of pityriasis rosea. Read More

View Article and Full-Text PDF
September 2020

Childhood Pityriasis Rosea With Multiple Herald Patches.

Cureus 2020 Aug 19;12(8):e9876. Epub 2020 Aug 19.

Emergency Medicine, University of Central Florida College of Medicine/HCA Healthcare University of Central Florida Graduate Medical Education Consortium Emergency Medicine Residency Program of Greater Orlando, Orlando, USA.

Pityriasis rosea is a common skin condition that mainly affects people in their mid to late 20s. The disease commonly begins with the presentation of a herald patch, followed by the spreading of smaller lesions. The authors of this case look at a school-age male child with pityriasis rosea that originated on his back and spread to his chest, legs, arms, and buttocks. Read More

View Article and Full-Text PDF